Dynamic Contrast-Enhanced MR Perfusion in Differentiation of Benign and Malignant Brain Lesions
- 1 September 2022
- journal article
- research article
- Published by Bentham Science Publishers Ltd. in Current Medical Imaging
- Vol. 18 (10) , 1099-1105
Abstract
Background: We aimed to differentiate Glioblastoma Multiforme (GBM) from benign lesions like Developmental Venous Anomaly (DVA) and Cavernous Malformation (CM) by Dynamic Contrast-Enhanced MR Perfusion (DCE-MRP) markers such as Ktrans, Ve, Kep, and IAUC. Method: We retrospectively evaluated 20 patients; 10 GBM as the malignant group, 5 CM and 5 DVA as the benign group. Ktrans, Kep, Ve, and IAUC parameters were measured by DCE-MRP, within the lesion, at perilesional nonenhancing white matter (PLWM) and contralateral normal appearing white matter (CLWM). Result: All benign and malignant lesions exhibited significantly increased Ktrans, Ve, and IAUC values compared to PLWM and CLWM (p < 0.001, p=0.006 and p<0.001). Subtracted Kep values between lesion and PLWM were significantly different between the benign and malignant groups, as the malignant group exhibited higher subtracted Kep values (p 0.035). For the malignant group; Ktrans and IAUC values at the lesion were positively correlated (r 0.911), while Kep and Ve at CLWM were negatively and strongly correlated (r 0.798). For the benign group; Ktrans with Ve and Ktrans with IAUC at lesion (r 0.708 and r 0.816 respectively), Ktrans and IAUC at PLWM (r 0.809), Ktrans and IAUC at CLWM(r 0.798) were strongly and positively correlated. Ktrans, Ve, and IAUC values can be used to restrict the lesion in both groups. Conclusion: Ktrans strongly correlates with IAUC and they can be used instead of each other in both benign and malignant lesions. Classical DCE-MRP parameters cannot be used in the differentiation of malignant lesions from benign vascular lesions. However, subtracted Kep values can be used to differentiate GBM from benign vascular lesions.Keywords
This publication has 16 references indexed in Scilit:
- Evaluation of Microvascular Permeability with Dynamic Contrast-Enhanced MRI for the Differentiation of Primary CNS Lymphoma and Glioblastoma: Radiologic-Pathologic CorrelationAmerican Journal of Neuroradiology, 2014
- Dynamic Permeability and Quantitative SusceptibilityStroke, 2014
- Perfusion and vascular permeability: Basic concepts and measurement in DCE-CT and DCE-MRIDiagnostic and Interventional Imaging, 2013
- Magnetic Resonance Imaging Findings of Developmental Venous AnomaliesClinical Neuroradiology, 2013
- Glioma Grading Capability: Comparisons among Parameters from Dynamic Contrast-Enhanced MRI and ADC Value on DWIKorean Journal of Radiology, 2013
- Glioblastoma Mimicking an Arteriovenous MalformationFrontiers in Neurology, 2013
- Correlation of perfusion parameters on dynamic contrast‐enhanced MRI with prognostic factors and subtypes of breast cancersJournal of Magnetic Resonance Imaging, 2012
- Biology2011
- Magnetic Resonance Imaging Workbench: Analysis and Visualization of Dynamic Contrast-enhanced MR Imaging DataRadioGraphics, 2006
- Ultrastructural and immunocytochemical evidence that an incompetent blood-brain barrier is related to the pathophysiology of cavernous malformationsJournal of Neurology, Neurosurgery & Psychiatry, 2001